Literature DB >> 8578844

A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine.

E Race1, C A Stein, M D Wigg, A Baksh, M Addawe, P Frezza, J S Oxford.   

Abstract

The kinetics of inactivation of four different strains of HIV-1 (RF, MN, SF2 and IIIB) by beta-propiolactone (BPL) and binary ethylenimine (BEI) were studied under various conditions. The conditions that would be required for the reduction of virus infectivity by at least 10(20) TCID50 ml-1 were estimated on the basis of the experimental rates of inactivation obtained. A multiple step procedure including treatment with 0.2% BPL, 0.05% sodium cholate, 10 mM BEI and 0.02% formaldehyde was designed to inactivate HIV-1 for use as an experimental vaccine. Complete inactivation of virus infectivity was confirmed by prolonged cell culture. The experimental vaccine preparation was analysed for the presence of HIV-1 proviral DNA utilizing the polymerase chain reaction. After treatment with both BPL and BEI proviral DNA was detected in one of four samples using primers encoding a 244 bp segment of the pol region of the viral genome. Proviral DNA could not be detected in any of the four samples using primers encoding segments of > 400 bp in the gag and reverse transcriptase region.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578844     DOI: 10.1016/0264-410x(95)00086-g

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  AIDS vaccine development: let a thousand flowers bloom.

Authors:  J S Oxford; M Addawe; R Lambkin
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses.

Authors:  Joost P Uittenbogaard; Bert Zomer; Peter Hoogerhout; Bernard Metz
Journal:  J Biol Chem       Date:  2011-08-25       Impact factor: 5.157

3.  Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope.

Authors:  Yossef Raviv; Mathias Viard; Julian W Bess; Elena Chertova; Robert Blumenthal
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.